Department of Surgery
2007 Smithy Lecture
Dr. Douglas E. Wood received his undergraduate and medical degrees from Harvard University and trained in General Surgery and Cardiothoracic Surgery at the Massachusetts General Hospital in Boston. He then traveled to Seattle, Washington where he is Professor and Endowed Chair in Lung Cancer Research and is the Chief of General Thoracic Surgery, and the Associate Chief of the Division of Cardiothoracic Surgery at the University of Washington.
Dr. Wood and the thoracic surgery faculty at UW have developed a large and dynamic clinical and academic thoracic surgery program. The UW program has a strong emphasis on thoracic surgical education and has developed basic science research related to their end-stage lung disease programs. He has been very involved in postgraduate education, having been on the program committees of each of the major United States cardiothoracic societies and having led the general thoracic postgraduate programs at several of the surgical scientific meetings. Dr. Wood has been very involved in the leadership of cardiothoracic surgery professional organizations, serving on the Board of Directors and now as Secretary of the Society of Thoracic Surgeons, the Board of Directors of the United Network of Organ Sharing, and on the Executive Committee of the General Thoracic Surgical Club. He has held several leadership positions within the Western Thoracic Surgical Association and is currently the President of that society. Dr. Wood is one of the Directors of the American Board of Thoracic Surgery and serves as the Vice-Chair of the ACGME Residency Review Committee for Thoracic Surgery. Dr. Wood's clinical interests are in tracheobronchial pathology, thoracic oncology, and lung volume reduction surgery.
Dr. Wood developed one of the early programs in lung volume reduction surgery (LVRS) for severe emphysema at the University of Washington. Dr. Wood has performed over 250 LVRS operations and the UW program has performed over 400 LVRS procedures in the past 12 years. Dr. Wood was a major participant in the National Emphysema Treatment Trial where he was a Co-Principal Investigator; a member of the Steering Committee; the author of the surgical protocol; and a member of the writing committees for the primary outcomes paper, the cost-effectiveness paper, the surgical outcomes paper, the long-term outcomes paper, and the long-term cost-effectiveness paper.
Dr. Wood's other major area of interest is tracheobronchial pathology, and he has developed one of the largest interventional bronchoscopy programs in the U.S. This interest in bronchoscopic intervention and surgical therapy for emphysema has served as the basis for Dr. Wood's involvement in the evaluation of endobronchial therapy for emphysema. Dr. Wood is one of the Principal Investigators of the Spiration IBV™ clinical trial and has one of the largest personal experiences with the clinical placement of the IBV for palliation of severe emphysema.